KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Goodwill (2016 - 2025)

Historic Goodwill for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $3.0 billion.

  • Resmed's Goodwill rose 852.0% to $3.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 billion, marking a year-over-year increase of 852.0%. This contributed to the annual value of $3.0 billion for FY2025, which is 719.99% up from last year.
  • As of Q4 2025, Resmed's Goodwill stood at $3.0 billion, which was up 852.0% from $3.0 billion recorded in Q3 2025.
  • In the past 5 years, Resmed's Goodwill ranged from a high of $3.0 billion in Q2 2025 and a low of $1.9 billion during Q3 2021
  • Its 5-year average for Goodwill is $2.5 billion, with a median of $2.8 billion in 2023.
  • As far as peak fluctuations go, Resmed's Goodwill skyrocketed by 4504.23% in 2023, and later tumbled by 197.43% in 2024.
  • Resmed's Goodwill (Quarter) stood at $2.0 billion in 2021, then soared by 41.8% to $2.8 billion in 2022, then increased by 3.42% to $2.9 billion in 2023, then fell by 1.97% to $2.8 billion in 2024, then grew by 8.52% to $3.0 billion in 2025.
  • Its Goodwill stands at $3.0 billion for Q4 2025, versus $3.0 billion for Q3 2025 and $3.0 billion for Q2 2025.